Pharmaceutical Manufacturing of Omeprazole Extended-Release Capsules

The contract pertains to the manufacturing of Omeprazole Extended-Release Capsules identified by NSN 6505016247068, adhering strictly to FDA regulations, current Good Manufacturing Practices, and Department of Defense standards to ensure compliance for federal medical supply distribution. The product is intended for use within the military and federal healthcare systems, requiring full adherence to quality, safety, and packaging protocols mandated by federal authorities. The manufacturing facility must operate under cGMP conditions and be capable of consistent large-scale production to meet the supply chain demands of the Department of Defense. This subcontract opportunity, posted on July 26, 2026, with a response deadline of August 3, 2026, falls under NAICS code 325412 for pharmaceutical preparation manufacturing. The place of performance is specified as Fort Bragg with a zip code of 28310, indicating the primary logistics hub for distribution. The contracting agency is the Medical Supply Chain Pharm FSA under the Department of Defense, and the opportunity is accessible via the DIBBS platform. While no set-aside provisions or point of contact details are provided, bidders must be prepared to meet all federal pharmaceutical manufacturing and delivery requirements without deviation.